<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39439902</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Gut bacteria: an etiological agent in human pathological conditions.</ArticleTitle><Pagination><StartPage>1291148</StartPage><MedlinePgn>1291148</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1291148</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2024.1291148</ELocationID><Abstract><AbstractText>Through complex interactions with the host's immune and physiological systems, gut bacteria play a critical role as etiological agents in a variety of human diseases, having an impact that extends beyond their mere presence and affects the onset, progression, and severity of the disease. Gaining a comprehensive understanding of these microbial interactions is crucial to improving our understanding of disease pathogenesis and creating tailored treatment methods. Correcting microbial imbalances may open new avenues for disease prevention and treatment approaches, according to preliminary data. The gut microbiota exerts an integral part in the pathogenesis of numerous health conditions, including metabolic, neurological, renal, cardiovascular, and gastrointestinal problems as well as COVID-19, according to recent studies. The crucial significance of the microbiome in disease pathogenesis is highlighted by this role, which is comparable to that of hereditary variables. This review investigates the etiological contributions of the gut microbiome to human diseases, its interactions with the host, and the development of prospective therapeutic approaches. To fully harness the benefits of gut microbiome dynamics for improving human health, future research should address existing methodological challenges and deepen our knowledge of microbial interactions.</AbstractText><CopyrightInformation>Copyright © 2024 Islam, Mahbub, Hong and Chung.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Islam</LastName><ForeName>Md Minarul</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Institute for Medical Science, Jeonbuk National University Medical School, Jeonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mahbub</LastName><ForeName>Nasir Uddin</ForeName><Initials>NU</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Institute for Medical Science, Jeonbuk National University Medical School, Jeonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Seong-Tshool</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Institute for Medical Science, Jeonbuk National University Medical School, Jeonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Hea-Jong</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Gwangju Center, Korea Basic Science Institute, Gwangju, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001419" MajorTopicYN="N">Bacteria</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056265" MajorTopicYN="N">Microbial Interactions</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">gut-brain axis</Keyword><Keyword MajorTopicYN="N">metabolites</Keyword><Keyword MajorTopicYN="N">prebiotic</Keyword><Keyword MajorTopicYN="N">probiotic</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39439902</ArticleId><ArticleId IdType="pmc">PMC11493637</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2024.1291148</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abt M. C., Pamer E. G. (2014). Commensal bacteria mediated defenses against pathogens. Curr. Opin. Immunol. 29, 16–22. doi: 10.1016/j.coi.2014.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2014.03.003</ArticleId><ArticleId IdType="pmc">PMC4132187</ArticleId><ArticleId IdType="pubmed">24727150</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz K. F., Reyes N., Young K., Parikh K., Misra V., Alvina K. (2021). Altered gut microbiome and autism like behavior are associated with parental high salt diet in male mice. Sci. Rep. 11, 8364. doi: 10.1038/s41598-021-87678-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-87678-x</ArticleId><ArticleId IdType="pmc">PMC8052368</ArticleId><ArticleId IdType="pubmed">33863940</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzaal M., Saeed F., Shah Y. A., Hussain M., Rabail R., Socol C. T., et al. . (2022). Human gut microbiota in health and disease: Unveiling the relationship. Front. Microbiol. 13, 999001. doi: 10.3389/fmicb.2022.999001</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.999001</ArticleId><ArticleId IdType="pmc">PMC9549250</ArticleId><ArticleId IdType="pubmed">36225386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadian F., Razmpoosh E., Ejtahed H. S., Javadi M., Mirmiran P., Azizi F. (2022). Effects of probiotic supplementation on major cardiovascular-related parameters in patients with type-2 diabetes mellitus: a secondary-data analysis of a randomized double-blind controlled trial. Diabetol. Metab. Syndr. 14, 52. doi: 10.1186/s13098-022-00822-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-022-00822-z</ArticleId><ArticleId IdType="pmc">PMC9006598</ArticleId><ArticleId IdType="pubmed">35418091</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipour Nosrani E., Tamtaji O. R., Alibolandi Z., Sarkar P., Ghazanfari M., Azami Tameh A., et al. . (2021). Neuroprotective effects of probiotics bacteria on animal model of Parkinson's disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study. J. Immunoassay Immunochem 42, 106–120. doi: 10.1080/15321819.2020.1833917</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2020.1833917</ArticleId><ArticleId IdType="pubmed">33078659</ArticleId></ArticleIdList></Reference><Reference><Citation>Amiri P., Hosseini S. A., Ghaffari S., Tutunchi H., Ghaffari S., Mosharkesh E., et al. . (2021). Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review. Front. Pharmacol. 12, 837509. doi: 10.3389/fphar.2021.837509</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.837509</ArticleId><ArticleId IdType="pmc">PMC8847574</ArticleId><ArticleId IdType="pubmed">35185553</ArticleId></ArticleIdList></Reference><Reference><Citation>Aniwan S., Tremaine W. J., Raffals L. E., Kane S. V., Loftus E. V., Jr. (2018). Antibiotic use and new-onset inflammatory bowel disease in olmsted county, minnesota: A population-based case-control study. J. Crohns Colitis 12, 137–144. doi: 10.1093/ecco-jcc/jjx135</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjx135</ArticleId><ArticleId IdType="pmc">PMC5881749</ArticleId><ArticleId IdType="pubmed">29029150</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki R., Kamikado K., Suda W., Takii H., Mikami Y., Suganuma N., et al. . (2017). A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation. Sci. Rep. 7, 43522. doi: 10.1038/srep43522</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43522</ArticleId><ArticleId IdType="pmc">PMC5333160</ArticleId><ArticleId IdType="pubmed">28252037</ArticleId></ArticleIdList></Reference><Reference><Citation>Balolong M. P., Bautista R. L. S., Ecarma N. C. A., Balolong E. C., Hallare A. V., Elegado F. B. (2017). Evaluating the anti-obesity potential of 4B1, a probiotic strain isolated from balao-balao, a traditional Philippine fermented food. Int. Food Res. J. 24, 819–824.</Citation></Reference><Reference><Citation>Bezirtzoglou E., Tsiotsias A., Welling G. W. (2011). Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 17, 478–482. doi: 10.1016/j.anaerobe.2011.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anaerobe.2011.03.009</ArticleId><ArticleId IdType="pubmed">21497661</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaustein R. A., Seed P. C., Hartmann E. M. (2021). Biotransformation of Doxorubicin Promotes Resilience in Simplified Intestinal Microbial Communities. mSphere 6 (3), e0006821. doi: 10.1128/mSphere.00068-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00068-21</ArticleId><ArticleId IdType="pmc">PMC8265622</ArticleId><ArticleId IdType="pubmed">34192503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco N., Noti M. (2021). The aging gut microbiome and its impact on host immunity. Genes Immun. 22, 289–303. doi: 10.1038/s41435-021-00126-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41435-021-00126-8</ArticleId><ArticleId IdType="pmc">PMC8054695</ArticleId><ArticleId IdType="pubmed">33875817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt H. S., Kara B. (2020). A new treatment for ulcerative colitis: Intracolonic and xyloglucan application. Eur. J. Inflammation 18. doi: 10.1177/2058739220942626</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2058739220942626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bravo J. A., Forsythe P., Chew M. V., Escaravage E., Savignac H. M., Dinan T. G., et al. . (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 108, 16050–16055. doi: 10.1073/pnas.1102999108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102999108</ArticleId><ArticleId IdType="pmc">PMC3179073</ArticleId><ArticleId IdType="pubmed">21876150</ArticleId></ArticleIdList></Reference><Reference><Citation>Buffington S. A., Di Prisco G. V., Auchtung T. A., Ajami N. J., Petrosino J. F., Costa-Mattioli M. (2016). Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165, 1762–1775. doi: 10.1016/j.cell.2016.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.06.001</ArticleId><ArticleId IdType="pmc">PMC5102250</ArticleId><ArticleId IdType="pubmed">27315483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullich C., Keshavarzian A., Garssen J., Kraneveld A., Perez-Pardo P. (2019). Gut vibes in parkinson's disease: the microbiota-gut-brain axis. Mov. Disord. Clin. Pract. 6, 639–651. doi: 10.1002/mdc3.12840</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.12840</ArticleId><ArticleId IdType="pmc">PMC6856467</ArticleId><ArticleId IdType="pubmed">31745471</ArticleId></ArticleIdList></Reference><Reference><Citation>Burokas A., Arboleya S., Moloney R. D., Peterson V. L., Murphy K., Clarke G., et al. . (2017). Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol. Psychiatry 82, 472–487. doi: 10.1016/j.biopsych.2016.12.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2016.12.031</ArticleId><ArticleId IdType="pubmed">28242013</ArticleId></ArticleIdList></Reference><Reference><Citation>Caminero A., Herran A. R., Nistal E., Perez-Andres J., Vaquero L., Vivas S., et al. . (2014). Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease. FEMS Microbiol. Ecol. 88, 309–319. doi: 10.1111/fem.2014.88.issue-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/fem.2014.88.issue-2</ArticleId><ArticleId IdType="pubmed">24499426</ArticleId></ArticleIdList></Reference><Reference><Citation>Cani P. D., Neyrinck A. M., Fava F., Knauf C., Burcelin R. G., Tuohy K. M., et al. . (2007). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374–2383. doi: 10.1007/s00125-007-0791-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-007-0791-0</ArticleId><ArticleId IdType="pubmed">17823788</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas-Deza D., Bernal-Monterde V., Aranda-Alonso A. N., Montil-Miguel E., Julian-Gomara A. B., Letona-Gimenez L., et al. . (2021). Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes. PloS One 16, e0261061. doi: 10.1371/journal.pone.0261061</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261061</ArticleId><ArticleId IdType="pmc">PMC8659616</ArticleId><ArticleId IdType="pubmed">34882740</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C. S., Kao C. Y. (2019). Current understanding of the gut microbiota shaping mechanisms. J. BioMed. Sci. 26, 59. doi: 10.1186/s12929-019-0554-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0554-5</ArticleId><ArticleId IdType="pmc">PMC6702754</ArticleId><ArticleId IdType="pubmed">31434568</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Hall S., Vitetta L. (2021). Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Rev. Med. Virol. 31, 1–13. doi: 10.1002/rmv.2211</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2211</ArticleId><ArticleId IdType="pmc">PMC7995004</ArticleId><ArticleId IdType="pubmed">34546607</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Xu X., Wu X., Cao H., Li X., Hou Z., et al. . (2022). A comparison of the composition and functions of the oral and gut microbiotas in Alzheimer’s patients. Front. Cell Infect. Microbiol. 12. doi: 10.3389/fcimb.2022.942460</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.942460</ArticleId><ArticleId IdType="pmc">PMC9448892</ArticleId><ArticleId IdType="pubmed">36093178</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Zhang S., Wu J., Ye T., Wang S., Wang P., et al. . (2020). Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clin. Chim. Acta 507, 236–241. doi: 10.1016/j.cca.2020.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.04.037</ArticleId><ArticleId IdType="pubmed">32376324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., D'souza R., Hong S. T. (2013). The role of gut microbiota in the gut-brain axis: current challenges and perspectives. Protein Cell 4, 403–414. doi: 10.1007/s13238-013-3017-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-013-3017-x</ArticleId><ArticleId IdType="pmc">PMC4875553</ArticleId><ArticleId IdType="pubmed">23686721</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. T., Yang N. S., Lin Y. C., Ho S. T., Li K. Y., Lin J. S., et al. . (2018). A combination of Lactobacillus Mali APS1 and dieting improved the efficacy of obesity treatment via manipulating gut microbiome in mice. Sci. Rep. 8, 6153. doi: 10.1038/s41598-018-23844-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23844-y</ArticleId><ArticleId IdType="pmc">PMC5906640</ArticleId><ArticleId IdType="pubmed">29670255</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W. T., Kantilal H. K., Davamani F. (2020). The mechanism of bacteroides fragilis toxin contributes to colon cancer formation. Malays J. Med. Sci. 27, 9–21. doi: 10.21315/mjms</Citation><ArticleIdList><ArticleId IdType="doi">10.21315/mjms</ArticleId><ArticleId IdType="pmc">PMC7444842</ArticleId><ArticleId IdType="pubmed">32863742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chlebicz-Wojcik A., Slizewska K. (2021). Probiotics, prebiotics, and synbiotics in the irritable bowel syndrome treatment: A review. Biomolecules 11. doi: 10.3390/biom11081154</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11081154</ArticleId><ArticleId IdType="pmc">PMC8412098</ArticleId><ArticleId IdType="pubmed">34439821</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi W. J., Dong H. J., Jeong H. U., Ryu D. W., Song S. M., Kim Y. R., et al. . (2020). Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes. Sci. Rep. 10, 869. doi: 10.1038/s41598-020-57615-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-57615-5</ArticleId><ArticleId IdType="pmc">PMC6972779</ArticleId><ArticleId IdType="pubmed">31964951</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu C., Yu L., Li Y., Guo H., Zhai Q., Chen W., et al. . (2023). Meta-analysis of randomized controlled trials of the effects of probiotics in Parkinson's disease. Food Funct. 14, 3406–3422. doi: 10.1039/D2FO03825K</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2FO03825K</ArticleId><ArticleId IdType="pubmed">36974511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung H. J., Nguyen T. T. B., Kim H. J., Hong S. T. (2018). Gut microbiota as a missing link between nutrients and traits of human. Front. Microbiol. 9, 1510. doi: 10.3389/fmicb.2018.01510</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01510</ArticleId><ArticleId IdType="pmc">PMC6043858</ArticleId><ArticleId IdType="pubmed">30034384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung H. J., Yu J. G., Lee I. A., Liu M. J., Shen Y. F., Sharma S. P., et al. . (2016). Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity. FEBS Open Bio 6, 64–76. doi: 10.1002/2211-5463.12024</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.12024</ArticleId><ArticleId IdType="pmc">PMC4794792</ArticleId><ArticleId IdType="pubmed">27047743</ArticleId></ArticleIdList></Reference><Reference><Citation>Collado M. C., Calabuig M., Sanz Y. (2007). Differences between the fecal microbiota of coeliac infants and healthy controls. Curr. Issues Intest Microbiol. 8, 9–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">17489434</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrêa-Oliveira R., Fachi J. L., Vieira A., Sato F. T., Vinolo M. A. (2016). Regulation of immune cell function by short-chain fatty acids. Clin. Transl. Immunol. 5, e73. doi: 10.1038/cti.2016.17</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2016.17</ArticleId><ArticleId IdType="pmc">PMC4855267</ArticleId><ArticleId IdType="pubmed">27195116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L. M., Weiner H. L. (2018). Microbiota signaling pathways that influence neurologic disease. Neurotherapeutics 15, 135–145. doi: 10.1007/s13311-017-0598-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-017-0598-8</ArticleId><ArticleId IdType="pmc">PMC5794708</ArticleId><ArticleId IdType="pubmed">29340928</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies G. A., Bryant A. R., Reynolds J. D., Jirik F. R., Sharkey K. A. (2006). Prion diseases and the gastrointestinal tract. Can. J. Gastroenterol. 20, 18–24. doi: 10.1155/2006/184528</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2006/184528</ArticleId><ArticleId IdType="pmc">PMC2538961</ArticleId><ArticleId IdType="pubmed">16432555</ArticleId></ArticleIdList></Reference><Reference><Citation>Degruttola A. K., Low D., Mizoguchi A., Mizoguchi E. (2016). Current understanding of dysbiosis in disease in human and animal models. Inflammation Bowel Dis. 22, 1137–1150. doi: 10.1097/MIB.0000000000000750</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000750</ArticleId><ArticleId IdType="pmc">PMC4838534</ArticleId><ArticleId IdType="pubmed">27070911</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghan P., Pourghassem Gargari B., Asghari Jafar-Abadi M. (2014). Oligofructose-enriched inulin improves some inflammatory markers and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized controlled clinical trial. Nutrition 30, 418–423. doi: 10.1016/j.nut.2013.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2013.09.005</ArticleId><ArticleId IdType="pubmed">24332524</ArticleId></ArticleIdList></Reference><Reference><Citation>Depommier C., Everard A., Druart C., Plovier H., Van Hul M., Vieira-Silva S., et al. . (2019). Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096–1103. doi: 10.1038/s41591-019-0495-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0495-2</ArticleId><ArticleId IdType="pmc">PMC6699990</ArticleId><ArticleId IdType="pubmed">31263284</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sousa Moraes L. F., Grzeskowiak L. M., De Sales Teixeira T. F., Gouveia Peluzio Mdo C. (2014). Intestinal microbiota and probiotics in celiac disease. Clin. Microbiol. Rev. 27, 482–489. doi: 10.1128/CMR.00106-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00106-13</ArticleId><ArticleId IdType="pmc">PMC4135898</ArticleId><ArticleId IdType="pubmed">24982318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson F. B., Stallings C., Origoni A., Katsafanas E., Savage C. L., Schweinfurth L. A., et al. . (2014). Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim Care Companion CNS Disord. 16. doi: 10.4088/PCC.13m01579</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/PCC.13m01579</ArticleId><ArticleId IdType="pmc">PMC4048142</ArticleId><ArticleId IdType="pubmed">24940526</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y., Bu F., Chen T., Shi G., Yuan X., Feng Z., et al. . (2021). A next-generation probiotic: Akkermansia muciniphila ameliorates chronic stress-induced depressive-like behavior in mice by regulating gut microbiota and metabolites. Appl. Microbiol. Biotechnol. 105, 8411–8426. doi: 10.1007/s00253-021-11622-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-021-11622-2</ArticleId><ArticleId IdType="pubmed">34617139</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Vincenzo F., Del Gaudio A., Petito V., Lopetuso L. R., Scaldaferri F. (2024). Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern. Emerg. Med. 19, 275–293. doi: 10.1007/s11739-023-03374-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-023-03374-w</ArticleId><ArticleId IdType="pmc">PMC10954893</ArticleId><ArticleId IdType="pubmed">37505311</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll J. P. K., Vazquez-Castellanos J. F., Schaub A. C., Schweinfurth N., Kettelhack C., Schneider E., et al. . (2022). Fecal microbiota transplantation (FMT) as an adjunctive therapy for depression-case report. Front. Psychiatry 13, 815422. doi: 10.3389/fpsyt.2022.815422</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.815422</ArticleId><ArticleId IdType="pmc">PMC8891755</ArticleId><ArticleId IdType="pubmed">35250668</ArticleId></ArticleIdList></Reference><Reference><Citation>Dooling S. W., Sgritta M., Wang I. C., Duque A., Costa-Mattioli M. (2022). The effect of limosilactobacillus reuteri on social behavior is independent of the adaptive immune system. mSystems 7, e0035822. doi: 10.1128/msystems.00358-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msystems.00358-22</ArticleId><ArticleId IdType="pmc">PMC9765170</ArticleId><ArticleId IdType="pubmed">36286493</ArticleId></ArticleIdList></Reference><Reference><Citation>Drabińska N., Krupa-Kozak U., Jarocka-Cyrta E. (2020). Intestinal Permeability in Children with Celiac Disease after the Administration of Oligofructose-Enriched Inulin into a Gluten-Free Diet-Results of a Randomized, Placebo-Controlled, Pilot Trial. Nutrients 12. doi: 10.3390/nu12061736</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061736</ArticleId><ArticleId IdType="pmc">PMC7352250</ArticleId><ArticleId IdType="pubmed">32531982</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan M., Wang Y., Zhang Q., Zou R., Guo M., Zheng H. (2021). Characteristics of gut microbiota in people with obesity. PloS One 16, e0255446. doi: 10.1371/journal.pone.0255446</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255446</ArticleId><ArticleId IdType="pmc">PMC8354443</ArticleId><ArticleId IdType="pubmed">34375351</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn A. B., Jordan S., Baker B. J., Carlson N. S. (2017). The maternal infant microbiome: considerations for labor and birth. MCN Am. J. Matern Child Nurs. 42, 318–325. doi: 10.1097/NMC.0000000000000373</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NMC.0000000000000373</ArticleId><ArticleId IdType="pmc">PMC5648605</ArticleId><ArticleId IdType="pubmed">28825919</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont H. L., Suescun J., Jiang Z. D., Brown E. L., Essigmann H. T., Alexander A. S., et al. . (2023). Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study. Front. Neurol. 14, 1104759. doi: 10.3389/fneur.2023.1104759</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1104759</ArticleId><ArticleId IdType="pmc">PMC10019775</ArticleId><ArticleId IdType="pubmed">36937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Engevik M. A., Luk B., Chang-Graham A. L., Hall A., Herrmann B., Ruan W., et al. . (2019). Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways. mBio 10 (3), e01087–e01019. doi: 10.1128/mBio.01087-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01087-19</ArticleId><ArticleId IdType="pmc">PMC6581858</ArticleId><ArticleId IdType="pubmed">31213556</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J., Wang H., Zhou Y., Zhang H., Zhou H., Zhang X. (2021). Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis. Exp. Mol. Med. 53, 772–787. doi: 10.1038/s12276-021-00617-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00617-8</ArticleId><ArticleId IdType="pmc">PMC8178360</ArticleId><ArticleId IdType="pubmed">34002011</ArticleId></ArticleIdList></Reference><Reference><Citation>Farida E., Nuraida L., Giriwono P. E., Jenie B. S. L. (2020). Lactobacillus rhamnosus Reduces Blood Glucose Level through Downregulation of Gluconeogenesis Gene Expression in Streptozotocin-Induced Diabetic Rats. Int. J. Food Sci. 2020, 6108575. doi: 10.1155/2020/6108575</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6108575</ArticleId><ArticleId IdType="pmc">PMC7201496</ArticleId><ArticleId IdType="pubmed">32399477</ArticleId></ArticleIdList></Reference><Reference><Citation>Farup P. G., Rudi K., Hestad K. (2016). Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome? BMC Gastroenterol. 16, 51. doi: 10.1186/s12876-016-0446-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-016-0446-z</ArticleId><ArticleId IdType="pmc">PMC4847229</ArticleId><ArticleId IdType="pubmed">27121286</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernández-Tomé S., Marin A. C., Ortega Moreno L., Baldan-Martin M., Mora-Gutiérrez I., Lanas-Gimeno A., et al. . (2019). Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease. Nutrients 11, 2605. doi: 10.3390/nu11112605</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11112605</ArticleId><ArticleId IdType="pmc">PMC6893616</ArticleId><ArticleId IdType="pubmed">31683517</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes D., Andreyev J. (2022). The role of the human gut microbiome in inflammatory bowel disease and radiation enteropathy. Microorganisms 10. doi: 10.3390/microorganisms10081613</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10081613</ArticleId><ArticleId IdType="pmc">PMC9415405</ArticleId><ArticleId IdType="pubmed">36014031</ArticleId></ArticleIdList></Reference><Reference><Citation>Filosa S., Di Meo F., Crispi S. (2018). Polyphenols-gut microbiota interplay and brain neuromodulation. Neural Regener. Res. 13, 2055–2059. doi: 10.4103/1673-5374.241429</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.241429</ArticleId><ArticleId IdType="pmc">PMC6199944</ArticleId><ArticleId IdType="pubmed">30323120</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg G., Fahlgren A., Horstedt P., Hammarstrom S., Hernell O., Hammarstrom M. L. (2004). Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am. J. Gastroenterol. 99, 894–904. doi: 10.1111/j.1572-0241.2004.04157.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2004.04157.x</ArticleId><ArticleId IdType="pubmed">15128357</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S., Toh H., Hase K., Oshima K., Nakanishi Y., Yoshimura K., et al. . (2011). Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 (7331), 543–547. doi: 10.1038/nature09646</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09646</ArticleId><ArticleId IdType="pubmed">21270894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gacesa R., Kurilshikov A., Vich Vila A., Sinha T., Klaassen M. A. Y., Bolte L. A., et al. . (2022). Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732–739. doi: 10.1038/s41586-022-04567-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04567-7</ArticleId><ArticleId IdType="pubmed">35418674</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao R., Zhu C., Li H., Yin M., Pan C., Huang L., et al. . (2018). Dysbiosis signatures of gut microbiota along the sequence from healthy, young patients to those with overweight and obesity. Obes. (Silver Spring) 26, 351–361. doi: 10.1002/oby.22088</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22088</ArticleId><ArticleId IdType="pubmed">29280312</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P. (2021). Inflammation in irritable bowel syndrome (IBS): role of psyllium fiber supplementation in decreasing inflammation and physiological management of IBS. Turk J. Gastroenterol. 32, 108–110. doi: 10.5152/tjg</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/tjg</ArticleId><ArticleId IdType="pmc">PMC8975494</ArticleId><ArticleId IdType="pubmed">33893774</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng S., Yang L., Cheng F., Zhang Z., Li J., Liu W., et al. . (2019). Gut microbiota are associated with psychological stress-induced defections in intestinal and blood-brain barriers. Front. Microbiol. 10:3067. doi: 10.3389/fmicb.2019.03067</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.03067</ArticleId><ArticleId IdType="pmc">PMC6974438</ArticleId><ArticleId IdType="pubmed">32010111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhardt S., Mohajeri M. H. (2018). Changes of colonic bacterial composition in parkinson's disease and other neurodegenerative diseases. Nutrients 10. doi: 10.3390/nu10060708</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10060708</ArticleId><ArticleId IdType="pmc">PMC6024871</ArticleId><ArticleId IdType="pubmed">29857583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaderi A., Banafshe H. R., Mirhosseini N., Moradi M., Karimi M. A., Mehrzad F., et al. . (2019). Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients. BMC Psychiatry 19, 77. doi: 10.1186/s12888-019-2059-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-019-2059-x</ArticleId><ArticleId IdType="pmc">PMC6383260</ArticleId><ArticleId IdType="pubmed">30791895</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorecki A. M., Preskey L., Bakeberg M. C., Kenna J. E., Gildenhuys C., Macdougall G., et al. . (2019). Altered gut microbiome in parkinson's disease and the influence of lipopolysaccharide in a human alpha-synuclein over-expressing mouse model. Front. Neurosci. 13, 839. doi: 10.3389/fnins.2019.00839</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00839</ArticleId><ArticleId IdType="pmc">PMC6693556</ArticleId><ArticleId IdType="pubmed">31440136</ArticleId></ArticleIdList></Reference><Reference><Citation>Gozd-Barszczewska A., Koziol-Montewka M., Barszczewski P., Mlodzinska A., Huminska K. (2017). Gut microbiome as a biomarker of cardiometabolic disorders. Ann. Agric. Environ. Med. 24, 416–422. doi: 10.26444/aaem/75456</Citation><ArticleIdList><ArticleId IdType="doi">10.26444/aaem/75456</ArticleId><ArticleId IdType="pubmed">28954482</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi E., Melli S., Dunca D., Terruzzi V. (2016). Unexpected improvement in core autism spectrum disorder symptoms after long-term treatment with probiotics. SAGE Open Med. Case Rep. 4, 2050313X16666231. doi: 10.1177/2050313X16666231</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050313X16666231</ArticleId><ArticleId IdType="pmc">PMC5006292</ArticleId><ArticleId IdType="pubmed">27621806</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarino M. P. L., Altomare A., Emerenziani S., Di Rosa C., Ribolsi M., Balestrieri P., et al. . (2020). Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults. Nutrients 12. doi: 10.3390/nu12041037</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12041037</ArticleId><ArticleId IdType="pmc">PMC7231265</ArticleId><ArticleId IdType="pubmed">32283802</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C., Zhou Q., Li M., Zhou L., Xu L., Zhang Y., et al. . (2020). Breastfeeding restored the gut microbiota in caesarean section infants and lowered the infection risk in early life. BMC Pediatr. 20, 532. doi: 10.1186/s12887-020-02433-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-020-02433-x</ArticleId><ArticleId IdType="pmc">PMC7690020</ArticleId><ArticleId IdType="pubmed">33238955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha S., Oh D., Lee S., Park J., Ahn J., Choi S., et al. . (2021). Altered gut microbiota in korean children with autism spectrum disorders. Nutrients 13. doi: 10.3390/nu13103300</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13103300</ArticleId><ArticleId IdType="pmc">PMC8539113</ArticleId><ArticleId IdType="pubmed">34684301</ArticleId></ArticleIdList></Reference><Reference><Citation>Haiser H. J., Gootenberg D. B., Chatman K., Sirasani G., Balskus E. P., Turnbaugh P. J. (2013). Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science. 341 (6143), 295–298. doi: 10.1126/science.1235872</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1235872</ArticleId><ArticleId IdType="pmc">PMC3736355</ArticleId><ArticleId IdType="pubmed">23869020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan N., Yang H. (2019). Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 7, e7502. doi: 10.7717/peerj.7502</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.7502</ArticleId><ArticleId IdType="pmc">PMC6699480</ArticleId><ArticleId IdType="pubmed">31440436</ArticleId></ArticleIdList></Reference><Reference><Citation>Holscher H. D. (2017). Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8 (2), 172–184. doi: 10.1080/19490976.2017.1290756</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2017.1290756</ArticleId><ArticleId IdType="pmc">PMC5390821</ArticleId><ArticleId IdType="pubmed">28165863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K., Wu Z. X., Chen X. Y., Wang J. Q., Zhang D., Xiao C., et al. . (2022). Microbiota in health and diseases. Signal Transduct Target Ther. 7, 135. doi: 10.1038/s41392-022-00974-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh P. S., Ho H. H., Hsieh S. H., Kuo Y. W., Tseng H. Y., Kao H. F., et al. . (2020). Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice. BMJ Open Diabetes Res. Care 8. doi: 10.1136/bmjdrc-2019-001028</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjdrc-2019-001028</ArticleId><ArticleId IdType="pmc">PMC7202753</ArticleId><ArticleId IdType="pubmed">32332068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh F. C., Lee C. L., Chai C. Y., Chen W. T., Lu Y. C., Wu C. S. (2013). Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr. Metab. (Lond) 10, 35. doi: 10.1186/1743-7075-10-35</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-7075-10-35</ArticleId><ArticleId IdType="pmc">PMC3637306</ArticleId><ArticleId IdType="pubmed">23590862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Das P., Lv X., Shi M., Aa J., Wang K., et al. . (2022). Effects of 'Healthy' Fecal microbiota transplantation against the deterioration of depression in fawn-hooded rats. mSystems 7, e0021822. doi: 10.1128/msystems.00218-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msystems.00218-22</ArticleId><ArticleId IdType="pmc">PMC9239139</ArticleId><ArticleId IdType="pubmed">35481347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X. F., Zhang W. Y., Wen Q., Chen W. J., Wang Z. M., Chen J., et al. . (2019). Fecal microbiota transplantation alleviates myocardial damage in myocarditis by restoring the microbiota composition. Pharmacol. Res. 139, 412–421. doi: 10.1016/j.phrs.2018.11.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.11.042</ArticleId><ArticleId IdType="pubmed">30508676</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye E., Hellström P. M, Sundler F., Chen J., Midtvedt T. (2001). Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am. J. Physiol. Gastrointest. Liver Physiol. 280 (3), G368–80. doi: 10.1152/ajpgi.2001.280.3.G368</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.2001.280.3.G368</ArticleId><ArticleId IdType="pubmed">11171619</ArticleId></ArticleIdList></Reference><Reference><Citation>Inlender T., Nissim-Eliraz E., Stavely R., Hotta R., Goldstein A. M., Yagel S., et al. . (2021). Homeostasis of mucosal glial cells in human gut is independent of microbiota. Sci. Rep. 11 (1), 12796. doi: 10.1038/s41598-021-92384-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92384-9</ArticleId><ArticleId IdType="pmc">PMC8211706</ArticleId><ArticleId IdType="pubmed">34140608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H. M., Lee K. E., Kim D. H. (2019). The Preventive and Curative Effects of Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 on Immobilization Stress-Induced Anxiety/Depression and Colitis in Mice. Nutrients 11. doi: 10.3390/nu11040819</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11040819</ArticleId><ArticleId IdType="pmc">PMC6521032</ArticleId><ArticleId IdType="pubmed">30979031</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasemi S., Emaneini M., Fazeli M. S., Ahmadinejad Z., Nomanpour B., Sadeghpour Heravi F., et al. . (2020). Toxigenic and non-toxigenic patterns I and biofilm-forming ability in Bacteroides fragilis strains isolated from patients diagnosed with colorectal cancer. Gut Pathog. 12, 28. doi: 10.1186/s13099-020-00366-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-020-00366-5</ArticleId><ArticleId IdType="pmc">PMC7273666</ArticleId><ArticleId IdType="pubmed">32518594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L., Li D., Feng N., Shamoon M., Sun Z., Ding L., et al. . (2017. 7046). Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice. Sci. Rep. 7. doi: 10.1038/s41598-017-07335-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07335-0</ArticleId><ArticleId IdType="pmc">PMC5539151</ArticleId><ArticleId IdType="pubmed">28765642</ArticleId></ArticleIdList></Reference><Reference><Citation>Jie Z., Xia H., Zhong S. L., Feng Q., Li S., Liang S., et al. . (2017). The gut microbiome in atherosclerotic cardiovascular disease. Nat. Commun. 8, 845. doi: 10.1038/s41467-017-00900-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00900-1</ArticleId><ArticleId IdType="pmc">PMC5635030</ArticleId><ArticleId IdType="pubmed">29018189</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph N., Clayton J. B., Hoops S. L., Linhardt C. A., Mohd Hashim A., Mohd Yusof B. N., et al. . (2020). Alteration of the gut microbiome in normal and overweight school children from selangor with lactobacillus fermented milk administration. Evol. Bioinform. Online 16, 1176934320965943. doi: 10.1177/1176934320965943</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1176934320965943</ArticleId><ArticleId IdType="pmc">PMC7686607</ArticleId><ArticleId IdType="pubmed">33281440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabeerdoss J., Sankaran V., Pugazhendhi S., Ramakrishna B. S. (2013). Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India. BMC Gastroenterol. 13, 20. doi: 10.1186/1471-230X-13-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-230X-13-20</ArticleId><ArticleId IdType="pmc">PMC3565871</ArticleId><ArticleId IdType="pubmed">23351032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabouridis P. S., Lasrado R., McCallum S., Chng S. H., Snippert H. J., Clevers H., et al. . (2015). Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron 85 (2), 289–295. doi: 10.1016/j.neuron.2014.12.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.037</ArticleId><ArticleId IdType="pmc">PMC4306542</ArticleId><ArticleId IdType="pubmed">25578362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Denman S. E., Morrison M., Yu Z., Dore J., Leclerc M., et al. . (2010). Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflammation Bowel Dis. 16, 2034–2042. doi: 10.1002/ibd.21319</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.21319</ArticleId><ArticleId IdType="pubmed">20848492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang N. R., Kim M. D. (2011). Tardive dyskinesia: treatment with aripiprazole. Clin. Psychopharmacol. Neurosci. 9, 1–8. doi: 10.9758/cpn.2011.9.1.1</Citation><ArticleIdList><ArticleId IdType="doi">10.9758/cpn.2011.9.1.1</ArticleId><ArticleId IdType="pmc">PMC3568649</ArticleId><ArticleId IdType="pubmed">23430384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang D., Li Z. P., Ji G. E. (2018). Anti-obesity effects of a mixture of fermented ginseng, BORI, and CH88 in high-fat diet-fed mice. J. Microbiol. Biotechnol. 28, 688–696. doi: 10.4014/jmb.1801.01016</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.1801.01016</ArticleId><ArticleId IdType="pubmed">29551020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang V., Wagner G. C., Ming X. (2014). Gastrointestinal dysfunction in children with autism spectrum disorders. Autism Res. 7, 501–506. doi: 10.1002/aur.1386</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aur.1386</ArticleId><ArticleId IdType="pubmed">24753336</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson F. H., Fak F., Nookaew I., Tremaroli V., Fagerberg B., Petranovic D., et al. . (2012. 1245). Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3. doi: 10.1038/ncomms2266</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2266</ArticleId><ArticleId IdType="pmc">PMC3538954</ArticleId><ArticleId IdType="pubmed">23212374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai C., Sugimoto K., Moritani I., Tanaka J., Oya Y., Inoue H., et al. . (2015). Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 15, 100. doi: 10.1186/s12876-015-0330-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-015-0330-2</ArticleId><ArticleId IdType="pmc">PMC4531509</ArticleId><ArticleId IdType="pubmed">26261039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedia S., Virmani S., Vuyyuru S. K., Kumar P., Kante B., Sahu P., et al. . (2022). Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut 71, 2401–2413. doi: 10.1136/gutjnl-2022-327811</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-327811</ArticleId><ArticleId IdType="pubmed">35973787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Shin Y. C., Kim T. Y., Kim Y., Lee Y. S., Lee S. H., et al. . (2021). Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development. Gut Microbes 13 (1), 1–20. doi: 10.1080/19490976.2021.1892441</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1892441</ArticleId><ArticleId IdType="pmc">PMC7946046</ArticleId><ArticleId IdType="pubmed">33678130</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E. S., Yoon B. H., Lee S. M., Choi M., Kim E. H., Lee B. W., et al. . (2022). Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency. Exp. Mol. Med. 54, 103–114. doi: 10.1038/s12276-022-00728-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00728-w</ArticleId><ArticleId IdType="pmc">PMC8894390</ArticleId><ArticleId IdType="pubmed">35115674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok C. R., Rose D., Hutkins R. (2023). Predicting personalized responses to dietary fiber interventions: opportunities for modulation of the gut microbiome to improve health. Annu. Rev. Food Sci. Technol. 14, 157–182. doi: 10.1146/annurev-food-060721-015516</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-food-060721-015516</ArticleId><ArticleId IdType="pubmed">36446139</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppel N., Maini Rekdal V., Balskus E. P. (2017). Chemical transformation of xenobiotics by the human gut microbiota. Science(New York N.Y.) 356 (6344), eaag2770. doi: 10.1126/science.aag2770</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aag2770</ArticleId><ArticleId IdType="pmc">PMC5534341</ArticleId><ArticleId IdType="pubmed">28642381</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopen A., Witjes J., Wortelboer K., Majait S., Prodan A., Levin E., et al. . (2022). Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study. Gut 71, 1577–1587. doi: 10.1136/gutjnl-2020-323297</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323297</ArticleId><ArticleId IdType="pmc">PMC9279853</ArticleId><ArticleId IdType="pubmed">34697034</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostic A. D., Gevers D., Pedamallu C. S., Michaud M., Duke F., Earl A. M., et al. . (2012). Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298. doi: 10.1101/gr.126573.111</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.126573.111</ArticleId><ArticleId IdType="pmc">PMC3266036</ArticleId><ArticleId IdType="pubmed">22009990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuai X. Y., Yao X. H., Xu L. J., Zhou Y. Q., Zhang L. P., Liu Y., et al. . (2021). Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation. Microb. Cell Fact 20, 98. doi: 10.1186/s12934-021-01589-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-021-01589-0</ArticleId><ArticleId IdType="pmc">PMC8120701</ArticleId><ArticleId IdType="pubmed">33985520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshmanan A. P., Al Za'abi M., Ali B. H., Terranegra A. (2021). The influence of the prebiotic gum acacia on the intestinal microbiome composition in rats with experimental chronic kidney disease. BioMed. Pharmacother. 133, 110992. doi: 10.1016/j.biopha.2020.110992</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110992</ArticleId><ArticleId IdType="pubmed">33202283</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapaquette P., Glasser A. L., Huett A., Xavier R. J., Darfeuille-Michaud A. (2010). Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol. 12, 99–113. doi: 10.1111/cmi.2010.12.issue-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.2010.12.issue-1</ArticleId><ArticleId IdType="pmc">PMC3743084</ArticleId><ArticleId IdType="pubmed">19747213</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen N., Vogensen F. K., Van Den Berg F. W., Nielsen D. S., Andreasen A. S., Pedersen B. K., et al. . (2010). Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One 5, e9085. doi: 10.1371/journal.pone.0009085</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009085</ArticleId><ArticleId IdType="pmc">PMC2816710</ArticleId><ArticleId IdType="pubmed">20140211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. S., Lee D., Park G. S., Ko S. H., Park J., Lee Y. K., et al. . (2021). Lactobacillus plantarum HAC01 ameliorates type 2 diabetes in high-fat diet and streptozotocin-induced diabetic mice in association with modulating the gut microbiota. Food Funct. 12, 6363–6373. doi: 10.1039/D1FO00698C</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1FO00698C</ArticleId><ArticleId IdType="pubmed">34105563</ArticleId></ArticleIdList></Reference><Reference><Citation>Lew L. C., Hor Y. Y., Yusoff N. A. A., Choi S. B., Yusoff M. S. B., Roslan N. S., et al. . (2019). Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: A randomised, double-blind, placebo-controlled study. Clin. Nutr. 38, 2053–2064. doi: 10.1016/j.clnu.2018.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2018.09.010</ArticleId><ArticleId IdType="pubmed">30266270</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Chang Y., Zhang K., Chen H., Tao S., Zhang Z. (2020. b5450). Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Sci. Rep. 10. doi: 10.1038/s41598-020-62224-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62224-3</ArticleId><ArticleId IdType="pmc">PMC7096501</ArticleId><ArticleId IdType="pubmed">32214153</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N., Chen H., Cheng Y., Xu F., Ruan G., Ying S., et al. . (2021. a). Fecal microbiota transplantation relieves gastrointestinal and autism symptoms by improving the gut microbiota in an open-label study. Front. Cell. Infect. Microbiol. 11, 759435. doi: 10.3389/fcimb.2021.801376</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.801376</ArticleId><ArticleId IdType="pmc">PMC8560686</ArticleId><ArticleId IdType="pubmed">34737978</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., He J., Jia W. (2016. a). The influence of gut microbiota on drug metabolism and toxicity. Expert Opin. Drug Metab. Toxicol. 12, 31–40. doi: 10.1517/17425255.2016.1121234</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425255.2016.1121234</ArticleId><ArticleId IdType="pmc">PMC5683181</ArticleId><ArticleId IdType="pubmed">26569070</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., He Y., Ma J., Huang P., Du J., Cao L., et al. . (2019. a). Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota. Alzheimers Dement 15, 1357–1366. doi: 10.1016/j.jalz.2019.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.07.002</ArticleId><ArticleId IdType="pubmed">31434623</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Lin S., Vanhoutte P. M., Woo C. W., Xu A. (2016. b). Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in apoe-/- mice. Circulation 133, 2434–2446. doi: 10.1161/CIRCULATIONAHA.115.019645</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019645</ArticleId><ArticleId IdType="pubmed">27143680</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Luo X. F., Liu S. W., Zhao N., Li H. N., Zhang W., et al. . (2020. a). Abdominal massage reduces visceral hypersensitivity via regulating GDNF and PI3K/AKT signal pathway in a rat model of irritable bowel syndrome. Evid Based Complement Alternat Med. 2020, 3912931. doi: 10.1155/2020/3912931</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/3912931</ArticleId><ArticleId IdType="pmc">PMC7293735</ArticleId><ArticleId IdType="pubmed">32565856</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Song J., Ke P., Kong L., Lei B., Zhou J., et al. . (2021. b9743). The gut microbiome is associated with brain structure and function in schizophrenia. Sci. Rep. 11. doi: 10.1038/s41598-021-89166-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89166-8</ArticleId><ArticleId IdType="pmc">PMC8105323</ArticleId><ArticleId IdType="pubmed">33963227</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Wang M., Wang J., Li R., Zhang Y. (2019. b). Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Front. Cell Infect. Microbiol. 9, 206. doi: 10.3389/fcimb.2019.00206</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00206</ArticleId><ArticleId IdType="pmc">PMC6581668</ArticleId><ArticleId IdType="pubmed">31245306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y. C., Chen Y. T., Hsieh H. H., Chen M. J. (2016). Effect of APS1 and L. M1 on obesity and glucose homeostasis in diet-induced obese mice. J. Funct. Foods 23, 580–589. doi: 10.1016/j.jff.2016.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2016.03.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H., Guo Q., Wen Z., Tan S., Chen J., Lin L., et al. . (2021. a). The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors. Microb. Cell Fact 20, 233. doi: 10.1186/s12934-021-01720-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-021-01720-1</ArticleId><ArticleId IdType="pmc">PMC8715582</ArticleId><ArticleId IdType="pubmed">34963452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T. Y., Wu P. H., Lin Y. T., Hung S. C. (2021. b). Gut dysbiosis and mortality in hemodialysis patients. NPJ Biofilms Microbiomes 7, 20. doi: 10.1038/s41522-021-00191-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41522-021-00191-x</ArticleId><ArticleId IdType="pmc">PMC7930281</ArticleId><ArticleId IdType="pubmed">33658514</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Li E., Sun Z., Fu D., Duan G., Jiang M., et al. . (2019). Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder. Sci. Rep. 9, 287. doi: 10.1038/s41598-018-36430-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36430-z</ArticleId><ArticleId IdType="pmc">PMC6342986</ArticleId><ArticleId IdType="pubmed">30670726</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Moon C. D., Zheng N., Huws S., Zhao S., Wang J. (2022. a). Opportunities and challenges of using metagenomic data to bring uncultured microbes into cultivation. Microbiome 10, 76. doi: 10.1186/s40168-022-01272-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01272-5</ArticleId><ArticleId IdType="pmc">PMC9097414</ArticleId><ArticleId IdType="pubmed">35546409</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H. N., Wu H., Chen Y. Z., Chen Y. J., Shen X. Z., Liu T. T. (2017). Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Dig Liver Dis. 49, 331–337. doi: 10.1016/j.dld.2017.01.142</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2017.01.142</ArticleId><ArticleId IdType="pubmed">28179092</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhang R., Yao B., Yang J., Ge H., Zheng S., et al. . (2022. b). Metagenomics next-generation sequencing provides insights into the causative pathogens from critically ill patients with pneumonia and improves treatment strategies. Front. Cell Infect. Microbiol. 12, 1094518. doi: 10.3389/fcimb.2022.1094518</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1094518</ArticleId><ArticleId IdType="pmc">PMC9880068</ArticleId><ArticleId IdType="pubmed">36710980</ArticleId></ArticleIdList></Reference><Reference><Citation>Lkhagva E., Chung H. J., Ahn J. S., Hong S. T. (2021. a). Host factors affect the gut microbiome more significantly than diet shift. Microorganisms 9. doi: 10.3390/microorganisms9122520</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9122520</ArticleId><ArticleId IdType="pmc">PMC8707884</ArticleId><ArticleId IdType="pubmed">34946120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lkhagva E., Chung H. J., Hong J., Tang W. H. W., Lee S. I., Hong S. T., et al. . (2021. b). The regional diversity of gut microbiome along the GI tract of male C57BL/6 mice. BMC Microbiol. 21, 44. doi: 10.1186/s12866-021-02099-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-021-02099-0</ArticleId><ArticleId IdType="pmc">PMC7881553</ArticleId><ArticleId IdType="pubmed">33579191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Siles M., Martinez-Medina M., Suris-Valls R., Aldeguer X., Sabat-Mir M., Duncan S. H., et al. . (2016). Changes in the abundance of faecalibacterium prausnitzii phylogroups I and II in the intestinal mucosa of inflammatory bowel disease and patients with colorectal cancer. Inflammation Bowel Dis. 22, 28–41. doi: 10.1097/MIB.0000000000000590</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000590</ArticleId><ArticleId IdType="pubmed">26595550</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S., He L., Zhang H., Li Z., Liu C., Chen T. (2022). Arabinoxylan from rice bran protects mice against high-fat diet-induced obesity and metabolic inflammation by modulating gut microbiota and short-chain fatty acids. Food Funct. 13, 7707–7719. doi: 10.1039/D2FO00569G</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2FO00569G</ArticleId><ArticleId IdType="pubmed">35758533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahbub N. U., Islam M. M., Hong S.-T., Chung H.-J. (2024). Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration. Frontiers in Cellular and Infection Microbiology 14. doi: 10.3389/fcimb.2024.1348279</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2024.1348279</ArticleId><ArticleId IdType="pmc">PMC10904658</ArticleId><ArticleId IdType="pubmed">38435303</ArticleId></ArticleIdList></Reference><Reference><Citation>Majeed M., Nagabhushanam K., Natarajan S., Sivakumar A., Ali F., Pande A., et al. . (2016). Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study. Nutr. J. 15, 21. doi: 10.1186/s12937-016-0140-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-016-0140-6</ArticleId><ArticleId IdType="pmc">PMC4769834</ArticleId><ArticleId IdType="pubmed">26922379</ArticleId></ArticleIdList></Reference><Reference><Citation>Malla M. A., Dubey A., Kumar A., Yadav S., Hashem A., Abd Allah E. F. (2018). Exploring the human microbiome: the potential future role of next-generation sequencing in disease diagnosis and treatment. Front. Immunol. 9:2868. doi: 10.3389/fimmu.2018.02868</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02868</ArticleId><ArticleId IdType="pmc">PMC6330296</ArticleId><ArticleId IdType="pubmed">30666248</ArticleId></ArticleIdList></Reference><Reference><Citation>Mańkowska-Wierzbicka D., Stelmach-Mardas M., Gabryel M., Tomczak H., Skrzypczak-Zielińska M., Zakerska-Banaszak O., et al. . (2020). The effectiveness of multi-session FMT treatment in active ulcerative colitis patients: A pilot study. Biomedicines. 8, 268. doi: 10.3390/biomedicines8080268</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8080268</ArticleId><ArticleId IdType="pmc">PMC7459721</ArticleId><ArticleId IdType="pubmed">32756350</ArticleId></ArticleIdList></Reference><Reference><Citation>Marasco G., Di Biase A. R., Schiumerini R., Eusebi L. H., Iughetti L., Ravaioli F., et al. . (2016). Gut microbiota and celiac disease. Dig Dis. Sci. 61, 1461–1472. doi: 10.1007/s10620-015-4020-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-015-4020-2</ArticleId><ArticleId IdType="pubmed">26725064</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Cuesta M. C., Del Campo R., Garriga-Garcia M., Pelaez C., Requena T. (2021). Taxonomic characterization and short-chain fatty acids production of the obese microbiota. Front. Cell Infect. Microbiol. 11, 598093. doi: 10.3389/fcimb.2021.598093</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.598093</ArticleId><ArticleId IdType="pmc">PMC8242951</ArticleId><ArticleId IdType="pubmed">34222034</ArticleId></ArticleIdList></Reference><Reference><Citation>Martoni C. J., Srivastava S., Leyer G. J. (2020). Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial. Nutrients 12. doi: 10.3390/nu12020363</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12020363</ArticleId><ArticleId IdType="pmc">PMC7071206</ArticleId><ArticleId IdType="pubmed">32019158</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazur M., Furgala A., Jablonski K., Mach T., Thor P. (2012). Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients. Med. Sci. Monit 18, CR493–CR499. doi: 10.12659/MSM.883269</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.883269</ArticleId><ArticleId IdType="pmc">PMC3560712</ArticleId><ArticleId IdType="pubmed">22847198</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F., Zhang F., Meng M., Chen Q., Yang Y., Wang W., et al. . (2023). Effects of the synbiotic composed of mangiferin and Lactobacillus reuteri 1-12 on type 2 diabetes mellitus rats. Front. Microbiol. 14, 1158652. doi: 10.3389/fmicb.2023.1158652</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1158652</ArticleId><ArticleId IdType="pmc">PMC10157401</ArticleId><ArticleId IdType="pubmed">37152739</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani C., Duranti S., Bottacini F., Casey E., Turroni F., Mahony J., et al. . (2017). The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol. Mol. Biol. Rev. 81. doi: 10.1128/MMBR.00036-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00036-17</ArticleId><ArticleId IdType="pmc">PMC5706746</ArticleId><ArticleId IdType="pubmed">29118049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirsepasi-Lauridsen H. C., Vallance B. A., Krogfelt K. A., Petersen A. M. (2019). Escherichia coli pathobionts associated with inflammatory bowel disease. Clin. Microbiol. Rev. 32. doi: 10.1128/CMR.00060-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00060-18</ArticleId><ArticleId IdType="pmc">PMC6431131</ArticleId><ArticleId IdType="pubmed">30700431</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi M., Ogawa A., Higurashi S., Kadooka Y. (2014). Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur. J. Nutr. 53, 599–606. doi: 10.1007/s00394-013-0568-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-013-0568-9</ArticleId><ArticleId IdType="pubmed">23917447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri M. H., La Fata G., Steinert R. E., Weber P. (2018). Relationship between the gut microbiome and brain function. Nutr. Rev. 76, 481–496. doi: 10.1093/nutrit/nuy009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuy009</ArticleId><ArticleId IdType="pubmed">29701810</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao-Kitamoto H., Kamada N. (2017). Host-microbial cross-talk in inflammatory bowel disease. Immune Netw. 17, 1–12. doi: 10.4110/in.2017.17.1.1</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2017.17.1.1</ArticleId><ArticleId IdType="pmc">PMC5334117</ArticleId><ArticleId IdType="pubmed">28261015</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagpal R., Neth B. J., Wang S., Craft S., Yadav H. (2019). Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. EBioMedicine 47, 529–542. doi: 10.1016/j.ebiom.2019.08.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.08.032</ArticleId><ArticleId IdType="pmc">PMC6796564</ArticleId><ArticleId IdType="pubmed">31477562</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakabayashi I., Nakamura M., Kawakami K., Ohta T., Kato I., Uchida K., et al. . (2011). Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol. Dial Transplant. 26, 1094–1098. doi: 10.1093/ndt/gfq624</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfq624</ArticleId><ArticleId IdType="pubmed">20929916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakade Y., Iwata Y., Furuichi K., Mita M., Hamase K., Konno R., et al. . (2018). Gut microbiota-derived D-serine protects against acute kidney injury. JCI Insight 3. doi: 10.1172/jci.insight.97957</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.97957</ArticleId><ArticleId IdType="pmc">PMC6237464</ArticleId><ArticleId IdType="pubmed">30333299</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandwana V., Nandwana N. K., Das Y., Saito M., Panda T., Das S., et al. . (2022). The role of microbiome in brain development and neurodegenerative diseases. Molecules 27. doi: 10.3390/molecules27113402</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27113402</ArticleId><ArticleId IdType="pmc">PMC9182002</ArticleId><ArticleId IdType="pubmed">35684340</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan N., Pluznick J. L. (2014). From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. Am. J. Physiol. Cell Physiol. 307, C979–C985. doi: 10.1152/ajpcell.00228.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00228.2014</ArticleId><ArticleId IdType="pmc">PMC5243208</ArticleId><ArticleId IdType="pubmed">25273884</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemet I., Saha P. P., Gupta N., Zhu W., Romano K. A., Skye S. M., et al. . (2020). A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 180 862-877, e822. doi: 10.1016/j.cell.2020.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.016</ArticleId><ArticleId IdType="pmc">PMC7402401</ArticleId><ArticleId IdType="pubmed">32142679</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeld K. A., Kang N., Bienenstock J., Foster J. A. (2011. a). Effects of intestinal microbiota on anxiety-like behavior. Commun. Integr. Biol. 4, 492–494. doi: 10.4161/cib.15702</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cib.15702</ArticleId><ArticleId IdType="pmc">PMC3181531</ArticleId><ArticleId IdType="pubmed">21966581</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeld K. M., Kang N., Bienenstock J., Foster J. A. (2011. b). Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 23 255-264, e119. doi: 10.1111/nmo.2011.23.issue-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.2011.23.issue-3</ArticleId><ArticleId IdType="pubmed">21054680</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyrinck A. M., Possemiers S., Druart C., Van De Wiele T., De Backer F., Cani P. D., et al. . (2011). Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PloS One 6, e20944. doi: 10.1371/journal.pone.0020944</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020944</ArticleId><ArticleId IdType="pmc">PMC3111466</ArticleId><ArticleId IdType="pubmed">21695273</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T. T. B., Chung H. J., Kim H. J., Hong S. T. (2019). Establishment of an ideal gut microbiota to boost healthy growth of neonates. Crit. Rev. Microbiol. 45, 118–129. doi: 10.1080/1040841X.2018.1561643</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841X.2018.1561643</ArticleId><ArticleId IdType="pubmed">30773108</ArticleId></ArticleIdList></Reference><Reference><Citation>Niibo M., Shirouchi B., Umegatani M., Morita Y., Ogawa A., Sakai F., et al. . (2019). Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model. J. Dairy Sci. 102, 997–1006. doi: 10.3168/jds.2018-15203</Citation><ArticleIdList><ArticleId IdType="doi">10.3168/jds.2018-15203</ArticleId><ArticleId IdType="pubmed">30471910</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh D., Cheon K. A. (2020). Alteration of gut microbiota in autism spectrum disorder: an overview. Soa Chongsonyon Chongsin Uihak 31, 131–145. doi: 10.5765/jkacap.190039</Citation><ArticleIdList><ArticleId IdType="doi">10.5765/jkacap.190039</ArticleId><ArticleId IdType="pmc">PMC7350540</ArticleId><ArticleId IdType="pubmed">32665757</ArticleId></ArticleIdList></Reference><Reference><Citation>Okubo R., Koga M., Katsumata N., Odamaki T., Matsuyama S., Oka M., et al. . (2019). Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study. J. Affect. Disord. 245, 377–385. doi: 10.1016/j.jad.2018.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2018.11.011</ArticleId><ArticleId IdType="pubmed">30423465</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivares M., Castillejo G., Varea V., Sanz Y. (2014). Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br. J. Nutr. 112, 30–40. doi: 10.1017/S0007114514000609</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114514000609</ArticleId><ArticleId IdType="pubmed">24774670</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantoja-Feliciano I. G., Clemente J. C., Costello E. K., Perez M. E., Blaser M. J., Knight R., et al. . (2013). Biphasic assembly of the murine intestinal microbiota during early development. ISME J. 7, 1112–1115. doi: 10.1038/ismej.2013.15</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ismej.2013.15</ArticleId><ArticleId IdType="pmc">PMC3660675</ArticleId><ArticleId IdType="pubmed">23535917</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Kim M., Kang S. G., Jannasch A. H., Cooper B., Patterson J., et al. . (2015). Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 8 (1), 80–93. doi: 10.1038/mi.2014.44</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2014.44</ArticleId><ArticleId IdType="pmc">PMC4263689</ArticleId><ArticleId IdType="pubmed">24917457</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrono E., Svoboda J., Stuchlik A. (2021). Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis. Behav. Brain Funct. 17, 7. doi: 10.1186/s12993-021-00180-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12993-021-00180-2</ArticleId><ArticleId IdType="pmc">PMC8218443</ArticleId><ArticleId IdType="pubmed">34158061</ArticleId></ArticleIdList></Reference><Reference><Citation>Peddinti V., Avaghade M. M., Suthar S. U., Rout B., Gomte S. S., Agnihotri T. G., et al. . (2024). Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease. Clin. Nutr. ESPEN 60, 266–280. doi: 10.1016/j.clnesp.2024.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2024.02.019</ArticleId><ArticleId IdType="pubmed">38479921</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Munoz M. E., Arrieta M. C., Ramer-Tait A. E., Walter J. (2017). A critical assessment of the "sterile womb" and "in utero colonization" hypotheses: implications for research on the pioneer infant microbiome. Microbiome 5, 48. doi: 10.1186/s40168-017-0268-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0268-4</ArticleId><ArticleId IdType="pmc">PMC5410102</ArticleId><ArticleId IdType="pubmed">28454555</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry R. J., Peng L., Barry N. A., Cline G. W., Zhang D., Cardone R. L., et al. . (2016). Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature 534, 213–217. doi: 10.1038/nature18309</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18309</ArticleId><ArticleId IdType="pmc">PMC4922538</ArticleId><ArticleId IdType="pubmed">27279214</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce M., Seguella L., Del Re A., Lu J., Palenca I., Corpetti C., et al. . (2022). Next-generation probiotics for inflammatory bowel disease. Int. J. Mol. Sci. 23. doi: 10.3390/ijms23105466</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23105466</ArticleId><ArticleId IdType="pmc">PMC9141965</ArticleId><ArticleId IdType="pubmed">35628274</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer R. F. (1998). Gastrointestinal dysfunction in Parkinson's disease. Clin. Neurosci. 5, 136–146.</Citation><ArticleIdList><ArticleId IdType="pubmed">10785840</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan J., Nair D., Jain S., Montagne T., Flores D. V., Nguyen A., et al. . (2021). Alterations in gut microbiome composition and function in irritable bowel syndrome and increased probiotic abundance with daily supplementation. mSystems 6, e0121521. doi: 10.1128/mSystems.01215-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSystems.01215-21</ArticleId><ArticleId IdType="pmc">PMC8562475</ArticleId><ArticleId IdType="pubmed">34726487</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao Y., Sun J., Xia S., Tang X., Shi Y., Le G. (2014). Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct. 5, 1241–1249. doi: 10.1039/c3fo60630a</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3fo60630a</ArticleId><ArticleId IdType="pubmed">24722352</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley E. M. M. (2017). Microbiota-brain-gut axis and neurodegenerative diseases. Curr. Neurol. Neurosci. Rep. 17, 94. doi: 10.1007/s11910-017-0802-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-017-0802-6</ArticleId><ArticleId IdType="pubmed">29039142</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajilic-Stojanovic M., Biagi E., Heilig H. G., Kajander K., Kekkonen R. A., Tims S., et al. . (2011). Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792–1801. doi: 10.1053/j.gastro.2011.07.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2011.07.043</ArticleId><ArticleId IdType="pubmed">21820992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramezani A., Massy Z. A., Meijers B., Evenepoel P., Vanholder R., Raj D. S. (2016). Role of the gut microbiome in uremia: A potential therapeutic target. Am. J. Kidney Dis. 67, 483–498. doi: 10.1053/j.ajkd.2015.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.09.027</ArticleId><ArticleId IdType="pmc">PMC5408507</ArticleId><ArticleId IdType="pubmed">26590448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan N., Patel B. G., Ranganathan P., Marczely J., Dheer R., Pechenyak B., et al. . (2006). In vitro and in vivo assessment of intraintestinal bacteriotherapy in chronic kidney disease. ASAIO J. 52, 70–79. doi: 10.1097/01.mat.0000191345.45735.00</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mat.0000191345.45735.00</ArticleId><ArticleId IdType="pubmed">16436893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan N., Ranganathan P., Friedman E. A., Joseph A., Delano B., Goldfarb D. S., et al. . (2010). Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv. Ther. 27, 634–647. doi: 10.1007/s12325-010-0059-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-010-0059-9</ArticleId><ArticleId IdType="pubmed">20721651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao J., Xie R., Lin L., Jiang J., Du L., Zeng X., et al. . (2021). Fecal microbiota transplantation ameliorates gut microbiota imbalance and intestinal barrier damage in rats with stress-induced depressive-like behavior. Eur. J. Neurosci. 53, 3598–3611. doi: 10.1111/ejn.15192</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15192</ArticleId><ArticleId IdType="pubmed">33742731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen H. S., Holtug K., Mortensen P. B. (1988). Degradation of amino acids to short-chain fatty acids in humans. An in vitro study. Scand. J. Gastroenterol. 23, 178–182. doi: 10.3109/00365528809103964</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365528809103964</ArticleId><ArticleId IdType="pubmed">3363290</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastall R. A., Gibson G. R. (2015). Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr. Opin. Biotechnol. 32, 42–46. doi: 10.1016/j.copbio.2014.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2014.11.002</ArticleId><ArticleId IdType="pubmed">25448231</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedel S., Pheiffer C., Johnson R., Louw J., Muller C. J. F. (2021). Intestinal barrier function and immune homeostasis are missing links in obesity and type 2 diabetes development. Front. Endocrinol. (Lausanne) 12, 833544. doi: 10.3389/fendo.2021.833544</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.833544</ArticleId><ArticleId IdType="pmc">PMC8821109</ArticleId><ArticleId IdType="pubmed">35145486</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha L. (2014). Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J. Gastroenterol. 20, 6759–6773. doi: 10.3748/wjg.v20.i22.6759</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i22.6759</ArticleId><ArticleId IdType="pmc">PMC4051916</ArticleId><ArticleId IdType="pubmed">24944467</ArticleId></ArticleIdList></Reference><Reference><Citation>Saiyasit N., Chunchai T., Prus D., Suparan K., Pittayapong P., Apaijai N., et al. . (2020). Gut dysbiosis develops before metabolic disturbance and cognitive decline in high-fat diet-induced obese condition. Nutrition 69, 110576. doi: 10.1016/j.nut.2019.110576</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2019.110576</ArticleId><ArticleId IdType="pubmed">31580986</ArticleId></ArticleIdList></Reference><Reference><Citation>Saji N., Murotani K., Hisada T., Tsuduki T., Sugimoto T., Kimura A., et al. . (2019). The relationship between the gut microbiome and mild cognitive impairment in patients without dementia: a cross-sectional study conducted in Japan. Sci. Rep. 9, 19227. doi: 10.1038/s41598-019-55851-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-55851-y</ArticleId><ArticleId IdType="pmc">PMC6920432</ArticleId><ArticleId IdType="pubmed">31852995</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvi P. S., Cowles R. A. (2021). Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease. Cells 10 (7), 1775. doi: 10.3390/cells10071775</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071775</ArticleId><ArticleId IdType="pmc">PMC8304699</ArticleId><ArticleId IdType="pubmed">34359944</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson T. R., Debelius J. W., Thron T., Janssen S., Shastri G. G., Ilhan Z. E., et al. . (2016). Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson's disease. Cell 167 1469-1480, e1412. doi: 10.1016/j.cell.2016.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.11.018</ArticleId><ArticleId IdType="pmc">PMC5718049</ArticleId><ArticleId IdType="pubmed">27912057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Alcoholado L., Castellano-Castillo D., Jordan-Martinez L., Moreno-Indias I., Cardila-Cruz P., Elena D., et al. . (2017. 1936). Role of gut microbiota on cardio-metabolic parameters and immunity in coronary artery disease patients with and without type-2 diabetes mellitus. Front. Microbiol. 8. doi: 10.3389/fmicb.2017.01936</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.01936</ArticleId><ArticleId IdType="pmc">PMC5633746</ArticleId><ArticleId IdType="pubmed">29051757</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Alcoholado L., Ramos-Molina B., Otero A., Laborda-Illanes A., Ordonez R., Medina J. A., et al. . (2020). The role of the gut microbiome in colorectal cancer development and therapy response. Cancers (Basel) 12. doi: 10.3390/cancers12061406</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12061406</ArticleId><ArticleId IdType="pmc">PMC7352899</ArticleId><ArticleId IdType="pubmed">32486066</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanekommu H., Taj S., Mah Noor R., Umair Akmal M., Akhtar R., Hossain M., et al. . (2023). Probiotics and fecal transplant: an intervention in delaying chronic kidney disease progression? Clin. Pract. 13, 881–888. doi: 10.3390/clinpract13040080</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/clinpract13040080</ArticleId><ArticleId IdType="pmc">PMC10453439</ArticleId><ArticleId IdType="pubmed">37623261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasso J. M., Ammar R. M., Tenchov R., Lemmel S., Kelber O., Grieswelle M., et al. . (2023). Gut microbiome-brain alliance: A landscape view into mental and gastrointestinal health and disorders. ACS Chem. Neurosci. 14, 1717–1763. doi: 10.1021/acschemneuro.3c00127</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.3c00127</ArticleId><ArticleId IdType="pmc">PMC10197139</ArticleId><ArticleId IdType="pubmed">37156006</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellekens H., Torres-Fuentes C., Van De Wouw M., Long-Smith C. M., Mitchell A., Strain C., et al. . (2021). Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human. EBioMedicine 63, 103176. doi: 10.1016/j.ebiom.2020.103176</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103176</ArticleId><ArticleId IdType="pmc">PMC7838052</ArticleId><ArticleId IdType="pubmed">33349590</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D. L. (2016). Quercetin as an augmentation agent in schizophrenia. J. Clin. Psychopharmacol. 36, 282–283. doi: 10.1097/JCP.0000000000000498</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCP.0000000000000498</ArticleId><ArticleId IdType="pubmed">27035495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sears C. L. (2009). Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin. Microbiol. Rev. 22, 349–369. doi: 10.1128/CMR.00053-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00053-08</ArticleId><ArticleId IdType="pmc">PMC2668231</ArticleId><ArticleId IdType="pubmed">19366918</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal A., Zlotnik Y., Moyal-Atias K., Abuhasira R., Ifergane G. (2021). Fecal microbiota transplant as a potential treatment for Parkinson's disease - A case series. Clin. Neurol. Neurosurg. 207, 106791. doi: 10.1016/j.clineuro.2021.106791</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2021.106791</ArticleId><ArticleId IdType="pubmed">34237681</ArticleId></ArticleIdList></Reference><Reference><Citation>Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., et al. . (2003). Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52, 237–242. doi: 10.1136/gut.52.2.237</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.52.2.237</ArticleId><ArticleId IdType="pmc">PMC1774977</ArticleId><ArticleId IdType="pubmed">12524406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgritta M., Dooling S. W., Buffington S. A., Momin E. N., Francis M. B., Britton R. A., et al. . (2019). Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron 101 246-259, e246. doi: 10.1016/j.neuron.2018.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.11.018</ArticleId><ArticleId IdType="pmc">PMC6645363</ArticleId><ArticleId IdType="pubmed">30522820</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaaban S. Y., El Gendy Y. G., Mehanna N. S., El-Senousy W. M., El-Feki H. S. A., Saad K., et al. . (2018). The role of probiotics in children with autism spectrum disorder: A prospective, open-label study. Nutr. Neurosci. 21, 676–681. doi: 10.1080/1028415X.2017.1347746</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2017.1347746</ArticleId><ArticleId IdType="pubmed">28686541</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaidullov I. F., Sorokina D. M., Sitdikov F. G., Hermann A., Abdulkhakov S. R., Sitdikova G. F. (2021). Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome. BMC Gastroenterol. 21, 37. doi: 10.1186/s12876-021-01613-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-021-01613-y</ArticleId><ArticleId IdType="pmc">PMC7836204</ArticleId><ArticleId IdType="pubmed">33499840</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Y., Forster S. C., Tsaliki E., Vervier K., Strang A., Simpson N., et al. . (2019). Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature 574, 117–121. doi: 10.1038/s41586-019-1560-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1560-1</ArticleId><ArticleId IdType="pmc">PMC6894937</ArticleId><ArticleId IdType="pubmed">31534227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Tripathi P. (2019). Gut microbiome and type 2 diabetes: where we are and where to go? J. Nutr. Biochem. 63, 101–108. doi: 10.1016/j.jnutbio.2018.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2018.10.003</ArticleId><ArticleId IdType="pubmed">30366260</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemin D., Bostom A. G., Laliberty P., Dworkin L. D. (2001). Residual renal function and mortality risk in hemodialysis patients. Am. J. Kidney Dis. 38, 85–90. doi: 10.1053/ajkd.2001.25198</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2001.25198</ArticleId><ArticleId IdType="pubmed">11431186</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S., Cho K. Y. (2020). Altered gut microbiota and shift in bacteroidetes between young obese and normal-weight korean children: A cross-sectional observational study. BioMed. Res. Int. 2020, 6587136. doi: 10.1155/2020/6587136</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6587136</ArticleId><ArticleId IdType="pmc">PMC7450312</ArticleId><ArticleId IdType="pubmed">32908903</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin D. S., Rhee K. J., Eom Y. B. (2020). Effect of Probiotic Clostridium butyricum NCTC 7423 Supernatant on Biofilm Formation and Gene Expression of Bacteroides fragilis. J. Microbiol. Biotechnol. 30, 368–377. doi: 10.4014/jmb.2001.01027</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.2001.01027</ArticleId><ArticleId IdType="pmc">PMC9728305</ArticleId><ArticleId IdType="pubmed">32066216</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirouchi B., Nagao K., Umegatani M., Shiraishi A., Morita Y., Kai S., et al. . (2016). Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure. Br. J. Nutr. 116, 451–458. doi: 10.1017/S0007114516002245</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114516002245</ArticleId><ArticleId IdType="pubmed">27267802</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman R. J., Hollister E. B., Cain K., Czyzewski D. I., Self M. M., Weidler E. M., et al. . (2017). Psyllium fiber reduces abdominal pain in children with irritable bowel syndrome in a randomized, double-blind trial. Clin. Gastroenterol. Hepatol. 15 712-719, e714. doi: 10.1016/j.cgh.2016.03.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2016.03.045</ArticleId><ArticleId IdType="pmc">PMC5064811</ArticleId><ArticleId IdType="pubmed">27080737</ArticleId></ArticleIdList></Reference><Reference><Citation>Silk D. B., Davis A., Vulevic J., Tzortzis G., Gibson G. R. (2009). Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol. Ther. 29, 508–518. doi: 10.1111/j.1365-2036.2008.03911.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2008.03911.x</ArticleId><ArticleId IdType="pubmed">19053980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobhani I., Bergsten E., Couffin S., Amiot A., Nebbad B., Barau C., et al. . (2019). Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc. Natl. Acad. Sci. U.S.A. 116, 24285–24295. doi: 10.1073/pnas.1912129116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1912129116</ArticleId><ArticleId IdType="pmc">PMC6883805</ArticleId><ArticleId IdType="pubmed">31712445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi M., Sahu B., Kaur H., Hasler W. A., Prakash A., Combs C. K. (2022). Gastrointestinal changes and alzheimer's disease. Curr. Alzheimer Res. 19, 335–350. doi: 10.2174/1567205019666220617121255</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205019666220617121255</ArticleId><ArticleId IdType="pmc">PMC10497313</ArticleId><ArticleId IdType="pubmed">35718965</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C., Satani N. (2011). The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol. Med. 17, 14–24. doi: 10.1016/j.molmed.2010.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2010.09.001</ArticleId><ArticleId IdType="pmc">PMC3056171</ArticleId><ArticleId IdType="pubmed">20889378</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenbergen L., Sellaro R., Van Hemert S., Bosch J. A., Colzato L. S. (2015). A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav. Immun. 48, 258–264. doi: 10.1016/j.bbi.2015.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.04.003</ArticleId><ArticleId IdType="pubmed">25862297</ArticleId></ArticleIdList></Reference><Reference><Citation>Strati F., Cavalieri D., Albanese D., De Felice C., Donati C., Hayek J., et al. . (2017). New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5, 24. doi: 10.1186/s40168-017-0242-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0242-1</ArticleId><ArticleId IdType="pmc">PMC5320696</ArticleId><ArticleId IdType="pubmed">28222761</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup T. S., Gray N. (2018). Management of common adverse effects of antipsychotic medications. World Psychiatry 17, 341–356. doi: 10.1002/wps.20567</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20567</ArticleId><ArticleId IdType="pmc">PMC6127750</ArticleId><ArticleId IdType="pubmed">30192094</ArticleId></ArticleIdList></Reference><Reference><Citation>Suganya K., Koo B. S. (2020). Gut-brain axis: role of gut microbiota on neurological disorders and how probiotics/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int. J. Mol. Sci. 21. doi: 10.3390/ijms21207551</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21207551</ArticleId><ArticleId IdType="pmc">PMC7589356</ArticleId><ArticleId IdType="pubmed">33066156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Song Z. G., Liu C., Tan S., Lin S., Zhu J., et al. . (2022. b). Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients. BMC Med. 20, 24. doi: 10.1186/s12916-021-02212-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02212-0</ArticleId><ArticleId IdType="pmc">PMC8769945</ArticleId><ArticleId IdType="pubmed">35045853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Wang F., Hu X., Yang C., Xu H., Yao Y., et al. . (2018). Clostridium butyricum Attenuates Chronic Unpredictable Mild Stress-Induced Depressive-Like Behavior in Mice via the Gut-Brain Axis. J. Agric. Food Chem. 66, 8415–8421. doi: 10.1021/acs.jafc.8b02462</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.8b02462</ArticleId><ArticleId IdType="pubmed">30040410</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Zhao F., Liu Y., Ma T., Jin H., Quan K., et al. . (2022. a). Probiotics synergized with conventional regimen in managing Parkinson's disease. NPJ Parkinsons Dis. 8, 62. doi: 10.1038/s41531-022-00327-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-022-00327-6</ArticleId><ArticleId IdType="pmc">PMC9130297</ArticleId><ArticleId IdType="pubmed">35610236</ArticleId></ArticleIdList></Reference><Reference><Citation>Surdea-Blaga T., Baban A., Dumitrascu D. L. (2012). Psychosocial determinants of irritable bowel syndrome. World J. Gastroenterol. 18, 616–626. doi: 10.3748/wjg.v18.i7.616</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v18.i7.616</ArticleId><ArticleId IdType="pmc">PMC3281218</ArticleId><ArticleId IdType="pubmed">22363132</ArticleId></ArticleIdList></Reference><Reference><Citation>Takayama F., Taki K., Niwa T. (2003). Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am. J. Kidney Dis. 41, S142–S145. doi: 10.1053/ajkd.2003.50104</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/ajkd.2003.50104</ArticleId><ArticleId IdType="pubmed">12612972</ArticleId></ArticleIdList></Reference><Reference><Citation>Taki K., Takayama F., Niwa T. (2005). Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. J. Ren Nutr. 15, 77–80. doi: 10.1053/j.jrn.2004.09.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jrn.2004.09.028</ArticleId><ArticleId IdType="pubmed">15648012</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamburini S., Shen N., Wu H. C., Clemente J. C. (2016). The microbiome in early life: implications for health outcomes. Nat. Med. 22 (7), 713–722. doi: 10.1038/nm.4142</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4142</ArticleId><ArticleId IdType="pubmed">27387886</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniya M. A., Chung H. J., Al Mamun A., Alam S., Aziz M. A., Emon N. U., et al. . (2022). Role of gut microbiome in autism spectrum disorder and its therapeutic regulation. Front. Cell Infect. Microbiol. 12, 915701. doi: 10.3389/fcimb.2022.915701</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.915701</ArticleId><ArticleId IdType="pmc">PMC9355470</ArticleId><ArticleId IdType="pubmed">35937689</ArticleId></ArticleIdList></Reference><Reference><Citation>Thirion F., Speyer H., Hansen T. H., Nielsen T., Fan Y., Le Chatelier E., et al. . (2023). Alteration of gut microbiome in patients with schizophrenia indicates links between bacterial tyrosine biosynthesis and cognitive dysfunction. Biol. Psychiatry Glob Open Sci. 3, 283–291. doi: 10.1016/j.bpsgos.2022.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpsgos.2022.01.009</ArticleId><ArticleId IdType="pmc">PMC10140391</ArticleId><ArticleId IdType="pubmed">37124355</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S., Izard J., Walsh E., Batich K., Chongsathidkiet P., Clarke G., et al. . (2017). The host microbiome regulates and maintains human health: A primer and perspective for non-microbiologists. Cancer Res. 77, 1783–1812. doi: 10.1158/0008-5472.CAN-16-2929</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-16-2929</ArticleId><ArticleId IdType="pmc">PMC5392374</ArticleId><ArticleId IdType="pubmed">28292977</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson-Chagoyan O. C., Maldonado J., Gil A. (2005). Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin. Nutr. 24, 339–352. doi: 10.1016/j.clnu.2005.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2005.02.009</ArticleId><ArticleId IdType="pubmed">15896420</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian P., Chen Y., Zhu H., Wang L., Qian X., Zou R., et al. . (2022). Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: A randomized clinical trial. Brain Behav. Immun. 100, 233–241. doi: 10.1016/j.bbi.2021.11.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.11.023</ArticleId><ArticleId IdType="pubmed">34875345</ArticleId></ArticleIdList></Reference><Reference><Citation>Troseid M., Andersen G. O., Broch K., Hov J. R. (2020). The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine 52, 102649. doi: 10.1016/j.ebiom.2020.102649</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102649</ArticleId><ArticleId IdType="pmc">PMC7016372</ArticleId><ArticleId IdType="pubmed">32062353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah H., Arbab S., Tian Y., Liu C.-Q., Chen Y., Qijie L., et al. . (2023). The gut microbiota–brain axis in neurological disorder. Frontiers in Neuroscience 17. doi: 10.3389/fnins.2023.1225875</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1225875</ArticleId><ArticleId IdType="pmc">PMC10436500</ArticleId><ArticleId IdType="pubmed">37600019</ArticleId></ArticleIdList></Reference><Reference><Citation>Van De Merwe J. P., Schroder A. M., Wensinck F., Hazenberg M. P. (1988). The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives. Scand. J. Gastroenterol. 23, 1125–1131. doi: 10.3109/00365528809090179</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365528809090179</ArticleId><ArticleId IdType="pubmed">3247591</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tilburg M. A., Palsson O. S., Whitehead W. E. (2013). Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model. J. Psychosom Res. 74, 486–492. doi: 10.1016/j.jpsychores.2013.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2013.03.004</ArticleId><ArticleId IdType="pmc">PMC3673027</ArticleId><ArticleId IdType="pubmed">23731745</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataraman R., Madempudi R. S., Neelamraju J., Ahire J. J., Vinay H. R., Lal A., et al. . (2021). Effect of multi-strain probiotic formulation on students facing examination stress: a double-blind, placebo-controlled study. Probiotics Antimicrob. Proteins 13, 12–18. doi: 10.1007/s12602-020-09681-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12602-020-09681-4</ArticleId><ArticleId IdType="pubmed">32601955</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdam F. J., Fuentes S., De Jonge C., Zoetendal E. G., Erbil R., Greve J. W., et al. . (2013). Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obes. (Silver Spring) 21, E607–E615. doi: 10.1002/oby.20466</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.20466</ArticleId><ArticleId IdType="pubmed">23526699</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinelli V., Biscotti P., Martini D., Del Bo C., Marino M., Merono T., et al. . (2022). Effects of dietary fibers on short-chain fatty acids and gut microbiota composition in healthy adults: A systematic review. Nutrients 14. doi: 10.3390/nu14132559</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14132559</ArticleId><ArticleId IdType="pmc">PMC9268559</ArticleId><ArticleId IdType="pubmed">35807739</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinolo M. A., Rodrigues H. G., Nachbar R. T., Curi R. (2011). Regulation of inflammation by short chain fatty acids. Nutrients 3, 858–876. doi: 10.3390/nu3100858</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu3100858</ArticleId><ArticleId IdType="pmc">PMC3257741</ArticleId><ArticleId IdType="pubmed">22254083</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitetta L., Llewellyn H., Oldfield D. (2019). Gut dysbiosis and the intestinal microbiome: streptococcus thermophilus a key probiotic for reducing uremia. Microorganisms 7. doi: 10.3390/microorganisms7080228</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms7080228</ArticleId><ArticleId IdType="pmc">PMC6723445</ArticleId><ArticleId IdType="pubmed">31370220</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt N. M., Kerby R. L., Dill-Mcfarland K. A., Harding S. J., Merluzzi A. P., Johnson S. C., et al. . (2017). Gut microbiome alterations in Alzheimer’s disease. Sci. Rep. 7, 13537. doi: 10.1038/s41598-017-13601-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13601-y</ArticleId><ArticleId IdType="pmc">PMC5648830</ArticleId><ArticleId IdType="pubmed">29051531</ArticleId></ArticleIdList></Reference><Reference><Citation>Voigt A. Y., Costea P. I., Kultima J. R., Li S. S., Zeller G., Sunagawa S., et al. . (2015). Temporal and technical variability of human gut metagenomes. Genome Biol. 16, 73. doi: 10.1186/s13059-015-0639-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0639-8</ArticleId><ArticleId IdType="pmc">PMC4416267</ArticleId><ArticleId IdType="pubmed">25888008</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker L., Levine H., Jucker M. (2006). Koch's postulates and infectious proteins. Acta Neuropathol. 112, 1–4. doi: 10.1007/s00401-006-0072-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0072-x</ArticleId><ArticleId IdType="pmc">PMC8544537</ArticleId><ArticleId IdType="pubmed">16703338</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R. X., Lee J. S., Campbell E. L., Colgan S. P. Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin. Proc. Natl. Acad. Sci. U. S. A. (2020) 117 (21), 11648–11657. doi: 10.1073/pnas.1917597117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1917597117</ArticleId><ArticleId IdType="pmc">PMC7260972</ArticleId><ArticleId IdType="pubmed">32398370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Chen J., Li L., Zhang H., Pang D., Ouyang H., et al. . (2022). Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice. Microbiol. Spectr. 10, e0252422. doi: 10.1128/spectrum.02524-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02524-22</ArticleId><ArticleId IdType="pmc">PMC9769846</ArticleId><ArticleId IdType="pubmed">36318049</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L. W., Zhao F. Q. (2023). Microbial transmission, colonisation and succession: from pregnancy to infancy. Gut 72, 772–786. doi: 10.1136/gutjnl-2022-328970</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2022-328970</ArticleId><ArticleId IdType="pmc">PMC10086306</ArticleId><ArticleId IdType="pubmed">36720630</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X., He Y., Li H., Yu D., Na L., Sun T., et al. . (2019). Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients. Nutrition 61, 132–142. doi: 10.1016/j.nut.2018.10.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2018.10.038</ArticleId><ArticleId IdType="pubmed">30711862</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Liu Z., Dong X., Hu T., Wang L., Li J., et al. . (2018). Fecal microbiota transplantation from healthy donors reduced alcohol-induced anxiety and depression in an animal model of chronic alcohol exposure. Chin. J. Physiol. 61, 360–371. doi: 10.4077/CJP.2018.BAH633</Citation><ArticleIdList><ArticleId IdType="doi">10.4077/CJP.2018.BAH633</ArticleId><ArticleId IdType="pubmed">30580506</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Wang J., Cai J., Feng W., Wang Y., Liu Q., et al. . (2019). Protective Effect of Lactobacillus rhamnosus GG and its Supernatant against Myocardial Dysfunction in Obese Mice Exposed to Intermittent Hypoxia is Associated with the Activation of Nrf2 Pathway. Int. J. Biol. Sci. 15, 2471–2483. doi: 10.7150/ijbs.36465</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.36465</ArticleId><ArticleId IdType="pmc">PMC6775312</ArticleId><ArticleId IdType="pubmed">31595164</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Wang C., Krolick K. N., Shi H., Zhu J. (2020). Difference in post-stress recovery of the gut microbiome and its altered metabolism after chronic adolescent stress in rats. Sci. Rep. 10, 3950. doi: 10.1038/s41598-020-60862-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-60862-1</ArticleId><ArticleId IdType="pmc">PMC7054252</ArticleId><ArticleId IdType="pubmed">32127581</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue L. J., Yang X. Z., Tong Q., Shen P., Ma S. J., Wu S. N., et al. . (2020). Fecal microbiota transplantation therapy for Parkinson's disease: A preliminary study. Med. (Baltimore) 99, e22035. doi: 10.1097/MD.0000000000022035</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000022035</ArticleId><ArticleId IdType="pmc">PMC7458210</ArticleId><ArticleId IdType="pubmed">32871960</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan A., Culp E., Perry J., Lau J. T., MacNeil L. T., Surette M. G., et al. . (2018). Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome. ACS Infect. Dis. 4 (1), 68–76. doi: 10.1021/acsinfecdis.7b00166</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.7b00166</ArticleId><ArticleId IdType="pubmed">29160065</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y. K., Zuo T., Lui G. C., Zhang F., Liu Q., Li A. Y., et al. . (2021). Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698–706. doi: 10.1136/gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>You S., Ma Y., Yan B., Pei W., Wu Q., Ding C., et al. . (2022). The promotion mechanism of prebiotics for probiotics: A review. Front. Nutr. 9, 1000517. doi: 10.3389/fnut.2022.1000517</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.1000517</ArticleId><ArticleId IdType="pmc">PMC9581195</ArticleId><ArticleId IdType="pubmed">36276830</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F., Feng X., Li X., Luo Y., Wei M., Zhao T., et al. . (2021). Gut-derived metabolite phenylacetylglutamine and white matter hyperintensities in patients with acute ischemic stroke. Front. Aging Neurosci. 13, 675158. doi: 10.3389/fnagi.2021.675158</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.675158</ArticleId><ArticleId IdType="pmc">PMC8363199</ArticleId><ArticleId IdType="pubmed">34393756</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S., Wang K. S., Meng H., Hou X. T., Xue J. C., Liu B. H., et al. . (2023). The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy. BioMed. Pharmacother. 165, 114893. doi: 10.1016/j.biopha.2023.114893</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114893</ArticleId><ArticleId IdType="pubmed">37352702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaharuddin L., Mokhtar N. M., Muhammad Nawawi K. N., Raja Ali R. A. (2019). A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer. BMC Gastroenterol. 19, 131. doi: 10.1186/s12876-019-1047-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-019-1047-4</ArticleId><ArticleId IdType="pmc">PMC6657028</ArticleId><ArticleId IdType="pubmed">31340751</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai C., Ahn J. S., Islam M. M., Lkhagva E., Chung H. J., Hong S. T. (2022. a). Comparative analysis of original and replaced gut microbiomes within same individuals identified the intestinal microbes associated with weight gaining. Microorganisms 10. doi: 10.3390/microorganisms10051062</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10051062</ArticleId><ArticleId IdType="pmc">PMC9144321</ArticleId><ArticleId IdType="pubmed">35630504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai T., Wang P., Hu X., Zheng L. (2022. b). Probiotics bring new hope for atherosclerosis prevention and treatment. Oxid. Med. Cell Longev 2022, 3900835. doi: 10.1155/2022/3900835</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3900835</ArticleId><ArticleId IdType="pmc">PMC9526629</ArticleId><ArticleId IdType="pubmed">36193065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Ni Y., Qian L., Fang Q., Zheng T., Zhang M., et al. . (2021). Decreased abundance of akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Adv. Sci. (Weinh) 8, e2100536. doi: 10.1002/advs.202100536</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202100536</ArticleId><ArticleId IdType="pmc">PMC8373164</ArticleId><ArticleId IdType="pubmed">34085773</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Si X., Yang L., Wang H., Sun Y., Liu N. (2022). Association between intestinal microbiota and inflammatory bowel disease. Anim. Model. Exp. Med. 5, 311–322. doi: 10.1002/ame2.12255</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ame2.12255</ArticleId><ArticleId IdType="pmc">PMC9434590</ArticleId><ArticleId IdType="pubmed">35808814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J. L., Wang S. B., Zeng Z., Qin Y. X., Shen Q., Li P. L. (2020). Anti-diabetic effects of 01 through improving hepatic insulin sensitivity in type 2 diabetic rat model. J. Funct. Foods 67. doi: 10.1016/j.jff.2020.103843</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2020.103843</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Xu J. H., Yu T., Chen Q. K. (2019). Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice. BioMed. Pharmacother. 118, 109131. doi: 10.1016/j.biopha.2019.109131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109131</ArticleId><ArticleId IdType="pubmed">31545226</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhen J., Zhou Z., He M., Han H. X., Lv E. H., Wen P. B., et al. . (2023). The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases. Front. Endocrinol. (Lausanne) 14, 1085041. doi: 10.3389/fendo.2023.1085041</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1085041</ArticleId><ArticleId IdType="pmc">PMC9941174</ArticleId><ArticleId IdType="pubmed">36824355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng P., Zeng B., Liu M., Chen J., Pan J., Han Y., et al. . (2019). The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci. Adv. 5 (2), eaau8317 10.1126/sciadv.aau8317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6365110</ArticleId><ArticleId IdType="pubmed">30775438</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H., Wang J., Abdullah, Hafeez M. A., Guan R., Feng F. (2021. a). Lactobacillus plantarum ZJUFB2 prevents high fat diet-induced insulin resistance in association with modulation of the gut microbiota. Front. Nutr. 8, 754222. doi: 10.3389/fnut.2021.754222</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.754222</ArticleId><ArticleId IdType="pmc">PMC8604096</ArticleId><ArticleId IdType="pubmed">34805244</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong H., Wang Y., Shi Z., Zhang L., Ren H., He W., et al. . (2021. b). Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients. Cell Discovery 7, 23. doi: 10.1038/s41421-021-00257-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00257-2</ArticleId><ArticleId IdType="pmc">PMC8043102</ArticleId><ArticleId IdType="pubmed">33850111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X., Shang G. S., Tan Q., He Q., Tan X., Park K. Y., et al. . (2021). Effect of Lactobacillus fermentum TKSN041 on improving streptozotocin-induced type 2 diabetes in rats. Food Funct. 12, 7938–7953. doi: 10.1039/D1FO01571K</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1FO01571K</ArticleId><ArticleId IdType="pubmed">34251007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Li Q., Jiang H. (2020). Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. APMIS 128, 353–366. doi: 10.1111/apm.13038</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.13038</ArticleId><ArticleId IdType="pmc">PMC7318354</ArticleId><ArticleId IdType="pubmed">32108960</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P. (2023). The immunological interplay between vaccination and the intestinal microbiota. NPJ Vaccines 8, 24. doi: 10.1038/s41541-023-00627-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-023-00627-9</ArticleId><ArticleId IdType="pmc">PMC9947885</ArticleId><ArticleId IdType="pubmed">36823142</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Ng S. C. (2018. 2247). The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front. Microbiol. 9. doi: 10.3389/fmicb.2018.02247</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02247</ArticleId><ArticleId IdType="pmc">PMC6167487</ArticleId><ArticleId IdType="pubmed">30319571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G. C. Y., Yeoh Y. K., Li A. Y. L., Zhan H., et al. . (2020). Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159 944-955, e948.x. doi: 10.1053/j.gastro.2020.05.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>